Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study

Table 1

Patients’ characteristics.

Variables	Combined group()	Control group ()	value
Age (year)			0.948
BMI (kg/m^2)			0.268
Gender (male : female)	19 : 12	18 : 13	0.773
TNM stage, (%)			0.460
III	3 (9.7)	2 (6.5)
IV	28 (90.3)	29 (93.5)
Tumor differentiation, (%)			0.658
Poorly differentiated	28 (90.3)	27 (87.1)
Moderately differentiated	3 (9.7)	4 (12.9)
KPS score			0.674